期刊文献+

子宫内膜癌腹水中一氧化氮及一氧化氮合酶检测意义的初探

The detection and significance of nitric oxide and activity of nitric oxide synthase in endometrial carcinoma ascites
下载PDF
导出
摘要 目的 检测子宫内膜癌及子宫肌瘤患者腹水中一氧化氮 (NO)及一氧化氮合酶 (NOS)的活性 ,探讨腹水中NO及NOS含量与子宫内膜癌之间的关系。方法 对 2 2例子宫内膜癌患者腹水进行NO及NOS测定并与子宫肌瘤组患者腹水进行比较。结果 子宫内膜癌患者腹水中NO浓度及NOS活性明显高于对照组 (P <0 .0 1) ,且随子宫内膜癌手术病理分期的增加 ,NO浓度及NOS活性增高 (P <0 .0 0 1) ,并与肿瘤恶性程度呈正相关。结论 NO浓度及NOS活性的增加可能参与了子宫内膜癌发生及肿瘤发展、生长过程 ,与手术病理分期有关。子宫内膜癌组织及腹水中NOS活性增高是NO合成增多的重要原因之一。 Objective To explore the relationship between the level of nitric oxide(NO) or activity of nitric oxide synthase (NOS) and endometrial carcinoma by detecting the content of NO and NOS activity in endometrium carcinoma ascites.Methods The concentration of NO and the activity of NOS in 22 patients of endometrial carcinoma ascites were evaluated and compared with normal control. Results The concentration of NO and the activity of NOS were significantly higher in endometrial carcinoma ascite than those in control group(P<0.01). The level of NOS activity gradually increased as the differentiating degree for the tumor decreased(P<0.05). There was a positive correlation between NOS activity and degree of malignance. Conclusion Increase of NO and NOS activity may play an important role in the occurrenceand development of endometrial carcinoma, and the increase of NO and NOS activity is associated with the differentiation of endometrial carcinoma. The increase of NO in edometrial neoplasm is mainly produced by the high level of NOS.
出处 《广东医学》 CAS CSCD 2004年第7期762-764,共3页 Guangdong Medical Journal
基金 广东省医药卫生科研基金资助项目 (编号 :A2 0 0 1190 )
关键词 子宫内膜癌 腹水 一氧化氮 一氧化氮合酶 检测 Endometrial neoplasm Ascites Nitric oxide Nitric oxide synthase
  • 相关文献

参考文献12

  • 1[1]Stahl SM. Nitric oxide physiology and pharmacology. J Clin Psychiatry,1998,59(3): 101
  • 2[2]Marsh N, Marsh A. A short history of nitroglycerine and nitric oxide in pharmacology and physiology. Clin Exp Pharmacol Physiol, 2000,27(4):313
  • 3[3]Anggard E. Nitric oxide: mediator, murderer, and medicine. Lancet,1994, 343(8907): 1199
  • 4[4]Noris M, Remuzzi G. Physiology and pathophysiology of nitric oxide in chronic renal disease. Proc Assoc Am Physicians, 1999, 111(6): 602
  • 5[5]Chan MM, Huang HI, Fenton MR, etal. In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti - inflammatory properties. Biochem Pharmacol, 1998,55(12):1955
  • 6[6]Sagar SM, Singh G, Modson DF, et al. Nitric oxide and anticancer therapy. Cancer Treat Rev, 1995,21 (2): 159
  • 7[7]Duenus GA, Isales CM, Pelmal AHM, et al. Expression of inducible nitric oxide synthase in breast cancer correlates with metastatic disease. Med Pathol, 1997,10(7) :645
  • 8[8]Cinel L, Polat A, Egilmez R, et al. bcl - 2, iNOS, p53 and PCNA expression in normal, disordered proliferative, hyperplastic and malignant endometrium. Pathol Int,2002, 52(5 ~ 6) :384
  • 9卢放根,方建珍,霍继荣,吴小平,凌奇荷.腹水中一氧化氮合成酶、一氧化氮及肿瘤坏死因子的研究[J].中华内科杂志,1996,35(11):744-746. 被引量:14
  • 10[12]Bentz BG, Barnes MN, Haines GK, et al. Cytoplasmic localization of endothelial constitutive nitric oxide synthase in endometrial carcinonas. Tumour Biol, 1997,18(5): 290

二级参考文献3

  • 1Noris M,Proc Assoc Am Physicians,1999年,111卷,6期,602页
  • 2Duenas G A,Mod Pathol,1997年,10卷,7期,645页
  • 3Sagar S M,Cancer Treat Rev,1995年,21卷,2期,159页

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部